Novacyt (NCYT) Competitors GBX 38.53 -0.17 (-0.44%) As of 11:05 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock NCYT vs. CREO, IUG, IHC, POLX, AVO, RUA, SUN, MHC, BELL, and MXCTShould you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), Belluscura (BELL), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry. Novacyt vs. Its Competitors Creo Medical Group Intelligent Ultrasound Group Inspiration Healthcare Group Polarean Imaging Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group MyHealthChecked Belluscura MaxCyte Novacyt (LON:NCYT) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk. Which has more risk & volatility, NCYT or CREO? Novacyt has a beta of -1.86, indicating that its share price is 286% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Which has stronger earnings & valuation, NCYT or CREO? Creo Medical Group has lower revenue, but higher earnings than Novacyt. Creo Medical Group is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovacyt£19.63M1.39-£36.80M-£0.59-65.30Creo Medical Group£4M13.30-£25.04M-£0.08-161.25 Is NCYT or CREO more profitable? Creo Medical Group has a net margin of -73.93% compared to Novacyt's net margin of -203.06%. Creo Medical Group's return on equity of -41.79% beat Novacyt's return on equity.Company Net Margins Return on Equity Return on Assets Novacyt-203.06% -47.73% -27.98% Creo Medical Group -73.93%-41.79%-20.09% Does the media refer more to NCYT or CREO? In the previous week, Creo Medical Group had 1 more articles in the media than Novacyt. MarketBeat recorded 1 mentions for Creo Medical Group and 0 mentions for Novacyt. Novacyt's average media sentiment score of 1.75 beat Creo Medical Group's score of 0.75 indicating that Novacyt is being referred to more favorably in the media. Company Overall Sentiment Novacyt Very Positive Creo Medical Group Positive Do institutionals & insiders have more ownership in NCYT or CREO? 10.7% of Novacyt shares are held by institutional investors. Comparatively, 45.1% of Creo Medical Group shares are held by institutional investors. 0.5% of Novacyt shares are held by company insiders. Comparatively, 4.1% of Creo Medical Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryCreo Medical Group beats Novacyt on 10 of the 13 factors compared between the two stocks. Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCYT vs. The Competition Export to ExcelMetricNovacytMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£27.21M£2.57B£5.78B£2.57BDividend YieldN/A2.44%6.70%5.30%P/E Ratio-65.30265.0175.845,395.93Price / Sales1.39153.97538.9997,029.82Price / Cash0.5815.9925.7027.93Price / Book0.393.7511.917.98Net Income-£36.80M£132.05M£3.28B£5.89B7 Day Performance-5.33%-2.93%1.11%0.63%1 Month Performance1.39%-4.81%8.17%55.78%1 Year Performance-53.64%12.84%67.79%197.77% Novacyt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCYTNovacytN/AGBX 38.53-0.4%N/A-53.4%£27.21M£19.63M-65.30120CREOCreo Medical GroupN/AGBX 13.13flatN/A-55.3%£53.06M£33.87M-2.08279News CoverageIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165IHCInspiration Healthcare GroupN/AGBX 22.70-0.4%N/A-0.5%£19.66M£42.87M-1.56224High Trading VolumePOLXPolarean ImagingN/AGBX 0.95flatN/A-43.1%£13.94M£5.21M-0.2428Gap DownAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.20-7.6%N/A+0.5%£6.95M£4.05M-2.6148High Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.67-4.9%N/A+2.6%£6.21M£12.54M-21.1180Gap UpMHCMyHealthCheckedN/AGBX 10.15-3.3%N/A-8.5%£5.28M£9.43M-5.0616BELLBelluscuraN/AGBX 0.75flatN/AN/A£1.89M£2.87M-0.0824MXCTMaxCyteN/AGBX 1.40+0.7%N/A-99.5%£1.85M£57.52M-0.0580High Trading Volume Related Companies and Tools Related Companies Creo Medical Group Alternatives Intelligent Ultrasound Group Alternatives Inspiration Healthcare Group Alternatives Polarean Imaging Alternatives Advanced Oncotherapy Alternatives RUA Life Sciences Alternatives Surgical Innovations Group Alternatives MyHealthChecked Alternatives Belluscura Alternatives MaxCyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:NCYT) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersNot “should you own gold?” … But “Do you have enough?”Gold has already broken out to new all-time highs — and silver looks ready to surge even faster as it plays ca...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The $100 billion DeFi prediction nobody's talking about The numbers are staggering: $38.5 billion TVL, $1 m...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novacyt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NCYT Stock Alerts